Photodynamic drug delivery enhancement in tumours does not depend on leukocyte-endothelial interaction in a human mesothelioma xenograft model

European Journal of Cardio-thoracic Surgery

Volumn 42, Issue 2, 2012, Pages 348-354

  Wang, Yabo ^a   Perentes, Jean Y ^a   Schäfer, Stephan C ^b   Gonzalez, Michel ^a   Debefve, Elodie ^c   Lehr, Hans Anton ^a   Van den bergh, Hubert ^c   Krueger, Thorsten ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

Dorsal skinfold chamber; Drug delivery; Intravital microscopy; Leukocyte; Malignant pleural mesothelioma; Photodynamic therapy

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; VERTEPORFIN; DEXTRAN; DRUG DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE; PHOTOSENSITIZING AGENT; PORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MALIGNANT MESOTHELIOMA; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKINFOLD; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; DRUG EFFECT; MESOTHELIOMA; METABOLISM; NUDE MOUSE; PLEURA TUMOR; VASCULAR ENDOTHELIUM;

ANIMALS; DEXTRANS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; LEUKOCYTES; MESOTHELIOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOTOSENSITIZING AGENTS; PLEURAL NEOPLASMS; PORPHYRINS;

EID: 84871708365     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr294     Document Type: Article

References (25)

1. Weder W. Mesothelioma. Ann Oncol 2010;21(Suppl. 7):vii326-33.
2. Stahel RA, Weder W, Lievens Y, Felip E. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Ann Oncol 2010;21(Suppl. 5):v126-8.
3. Tilleman TR, Richards WG, Zellos L, Johnson BE, Jaklitsch MT, Mueller J et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg 2009;138:405-11.
4. Ris HB, Altermatt HJ, Inderbitzi R, Hess R, Nachbur B, Stewart JC et al. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer 1991;64:1116-20.
5. Baas P, Murrer L, Zoetmulder FA, Stewart FA, Ris HB, van Zandwijk N et al. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer 1997;76:819-26.
6. Ris HB. Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma. Lung Cancer 2005;49(Suppl. 1):S65-8.
7. Pass HI, DeLaney TF, Tochner Z, Smith PE, Temeck BK, Pogrebniak HW et al. Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol 1994;1:28-37.
8. Debefve E, Mithieux F, Perentes JY, Wang Y, Cheng C, Schaefer SC et al. Leukocyte-endothelial cell interaction is necessary for photodynamic therapy induced vascular permeabilization. Lasers Surg Med 2011;43: 696-704.
9. Snyder JW, Greco WR, Bellnier DA, Vaughan L, Henderson BW. Photodynamic therapy: a means to enhanced drug delivery to tumors. Cancer Res 2003;63:8126-31.
10. Chen B, Pogue BW, Hoopes PJ, Hasan T. Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr 2006;16: 279-305.
11. Ris HB, Altermatt HJ, Stewart CM, Schaffner T, Wang Q, Lim CK et al. Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: optimization of the therapeutic index. Int J Cancer 1993;55:245-9.
12. Debefve E, Cheng C, Schaefer SC, Yan H, Ballini JP, van den Bergh H et al. Photodynamic therapy induces selective extravasation of macromolecules: insights using intravital microscopy. J Photochem Photobiol B 2010;98:69-76.
13. Pizcueta P, Luscinskas FW. Monoclonal antibody blockade of L-selectin inhibits mononuclear leukocyte recruitment to inflammatory sites in vivo. Am J Pathol 1994;145:461-9.
14. Lehr HA, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hubner C et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 1994;71:380-6.
15. Ramos CL, Kunkel EJ, Lawrence MB, Jung U, Vestweber D, Bosse R et al. Differential effect of E-selectin antibodies on neutrophil rolling and recruitment to inflammatory sites. Blood 1997;89:3009-18.
16. Dirkx AE, Oude Egbrink MG, Kuijpers MJ, van der Niet ST, Heijnen VV, Bouma-ter Steege JC et al. Tumor angiogenesis modulates leukocyte- vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res 2003;63:2322-9.
17. Cheng C, Debefve E, Haouala A, Andrejevic-Blant S, Krueger T, Ballini JP et al. Photodynamic therapy selectively enhances liposomal doxorubicin uptake in sarcoma tumors to rodent lungs. Lasers Surg Med 2010;42: 391-9.
18. Jehn CF, Boulikas T, Kourvetaris A, Possinger K, Luftner D. Pharmacokinetics of liposomal cisplatin (lipoplatin) in combination with 5-FU in patients with advanced head and neck cancer: first results of a phase III study. Anticancer Res 2007;27:471-5.
19. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 1997;26:71-90.
20. He C, Agharkar P, Chen B. Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy. Pharm Res 2008;25:1873-80.
21. Chen B, Crane C, He C, Gondek D, Agharkar P, Savellano MD et al. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy. Int J Cancer 2008;123:695-701.
22. Solban N, Selbo PK, Sinha AK, Chang SK, Hasan T. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer. Cancer Res 2006;66: 5633-40.
23. Wedmore CV, Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 1981;289: 646-50.
24. Dellian M, Abels C, Kuhnle GE, Goetz AE. Effects of photodynamic therapy on leucocyte-endothelium interaction: differences between normal and tumour tissue. Br J Cancer 1995;72:1125-30.
25. Fingar VH, Wieman TJ, Doak KW. Changes in tumor interstitial pressure induced by photodynamic therapy. Photochem Photobiol 1991;53: 763-8.